Description
This product utilizes CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD22 ( clone H9B322-206). We employs the pBR322 (T7-GFP-c-Fos-XbaI) vector components and the SynExpress system of the lncRNA Base Editing/Balancing feedback for a robust and sustained response against cancers.
Host
Mouse
Target
CD22
Clone
H9B322-206
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
GFP
Promoter
T7
Effector Gene
c-Fos
Insertion Sites
XbaI
Gene Modification
Base Editing
Modification Domain
lncRNA
Carrier Type
pBR322
Transformation Accuracy
0.91
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.